AP NEWS

The European Mesothelioma Market and Competitive Landscape (2018-2023) - ResearchAndMarkets.com

December 20, 2018

DUBLIN--(BUSINESS WIRE)--Dec 20, 2018--The “The European Mesothelioma Market and Competitive Landscape (2018-2023)” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights into Mesothelioma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Mesothelioma market size and drug sales. This research also provides insights into Mesothelioma epidemiology and late stage pipeline.

The research is classified into following sections - Mesothelioma overview with definitions, symptoms, etiology, diagnosis, treatment options; Mesothelioma pipeline insights covering late stage clinical trials pipeline; Mesothelioma prevalence trends by countries; Mesothelioma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope

Mesothelioma pipeline: Find out the drugs in clinical trials for Mesothelioma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Mesothelioma epidemiology: Find out the prevalence of Mesothelioma by countries - Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023 Mesothelioma products: Identify key products marketed and prescribed for Mesothelioma by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK Mesothelioma market size: Find out the market size for Mesothelioma drugs by countries - Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014 Mesothelioma drug sales: Find out the sales of Mesothelioma drugs by countries - Europe, Germany, France, Italy, Spain, UK Mesothelioma drugs sales forecast: Sales forecast for Mesothelioma drugs to 2023 by countries - Europe, Germany, France, Italy, Spain, UK Mesothelioma market share analysis: Find out the market shares of Mesothelioma drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK

Benefits of this Research

Evaluate commercial market opportunities for Mesothelioma drugs Synthesize insights for business development & licensing Track market size, competitor drug sales, market shares in Mesothelioma market Develop in-depth knowledge of competition and markets Analyze sales data to update your brand planning trackers Develop tactics and strategies to take advantage of opportunities in the market Track market trends and analyze key events in Mesothelioma market Develop forecast models, healthcare frameworks, or economic models Answer key business questions; supports decision making in R&D to long term marketing strategies

For more information about this report visit https://www.researchandmarkets.com/research/jp99r2/the_european?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181220005288/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/20/2018 05:49 AM/DISC: 12/20/2018 05:50 AM

http://www.businesswire.com/news/home/20181220005288/en

AP RADIO
Update hourly